Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
出版信息
Br Med J. 1978 Jun 3;1(6125):1466-7. doi: 10.1136/bmj.1.6125.1466.
Abstract
摘要
相似文献
1
Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.药品审查委员会。关于保泰松、羟基保泰松、非普拉宗、别嘌醇、秋水仙碱、丙磺舒和磺吡酮的建议。
Br Med J. 1978 Jun 3;1(6125):1466-7. doi: 10.1136/bmj.1.6125.1466.
2
Treatment of the gout and other forms of crystal-induced arthritis.痛风及其他形式的晶体诱导性关节炎的治疗。
Bull Rheum Dis. 1982;32(5):43-53.
3
Risks and benefits of drugs used in the management and prevention of gout.用于痛风管理和预防的药物的风险与益处。
Drug Saf. 1994 Oct;11(4):252-8. doi: 10.2165/00002018-199411040-00004.
4
Drugs for gout.治疗痛风的药物。
Med Lett Drugs Ther. 1976 Jun 4;18(12):49-51.
5
The management of gout.痛风的管理
Hosp Pract. 1979 Sep;14(9):75-8, 83-5. doi: 10.1080/21548331.1979.11707607.
6
Recent developments in the therapy of gout.痛风治疗的最新进展
J Am Geriatr Soc. 1968 May;16(5):499-504. doi: 10.1111/j.1532-5415.1968.tb02088.x.
7
[Antarthritics. 41].[抗关节炎药。41]
Pharm Prax. 1969 Dec;12:267-9.
8
Medical management of gout.痛风的医学管理
Postgrad Med. 1972 May;51(6):61-6. doi: 10.1080/00325481.1972.11698264.
9
Management of gout.
Am Fam Physician. 1979 Jan;19(1):91-7.
10
[How to treat gout].[如何治疗痛风]
Rev Esp Reum Enferm Osteoartic. 1966 Jul;11(7):497-523.
引用本文的文献
1
Phenylbutazone (Bute, PBZ, EPZ): one drug across two species.保泰松（布他酮、PBZ、EPZ）：一种适用于两个物种的药物。
Hist Philos Life Sci. 2018 Mar 26;40(2):27. doi: 10.1007/s40656-018-0191-4.
2
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?苯溴马隆治疗痛风的获益-风险评估。其退市符合患者的最大利益吗？
Drug Saf. 2008;31(8):643-65. doi: 10.2165/00002018-200831080-00002.
Zotero 插件